WhiMSICAL is a research and self-monitoring app designed for people living with Waldenström's macroglobulinaemia (WM), a rare type of blood cancer.
Developed in partnership with leading WM researchers, WhiMSICAL allows participants to record and track their health data over time, contributing to a global study that aims to improve understanding and treatment of WM.
For patients:
- Track your WM symptoms and how you're feeling over time
- Log pathology results and monitor your health trends
- Record your treatments, medications, and health milestones
- Complete quality of life assessments to understand how WM is affecting your daily life
- Review your data with your medical team
For research:
- Contribute to a global WM research study
- Help researchers understand disease progression and treatment patterns worldwide
- Support the development of better care pathways for WM patients everywhere
WhiMSICAL is part of a formal research study. Participation requires eligibility confirmation and study enrolment. The app is intended for use by people diagnosed with WM or Lymphoplasmacytic Lymphoma (LPL).
Your data is stored securely and handled in accordance with applicable privacy and research ethics requirements.
Developed on behalf of the SLHD Concord Haematology Clinical Research Unit, Sydney Local Health District.
Track and monitor your Waldenström's macroglobulinaemia health journey.